Dr. Arredouani’s research focuses mainly on the identification of biomarkers to predict Type 2 diabetes and its complications. He combines molecular and cellular techniques with systems biology approaches, including metabolomics and miRNA profiling, in his investigations.

CURRENT RESEARCH PROJECTS

• Fatty liver, Lifestyle and Glycaemia (FLAG): The impact of a low energy diet Intervention on non-alcoholic fatty liver disease in Type 2 diabetes in Qatar.
• Investigation of the association between low salivary alpha-amylase and risk of metabolic disorders in the Qatari population.
• Mechanisms underlying the improvement of NAFLD by GLP-1 agonists.